UNTERNEHMENSDATEN
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its …
KURSVERLAUF
1T
+3,3 %
1W
+5,8 %
1M
+2,3 %
6M
+5,7 %
YTD
+9,5 %
1J
+43,4 %
2J
+34,7 %
5J
+33,9 %
10J
+19,2 %
FRAG DIE AGENTEN ZU GSK
Keine Anlageberatung. Für die vollständige Analyse-Übersicht: zur Analyse-Seite →
ANALYSTEN-EINSCHÄTZUNG
KURSZIEL TIEF
35,25 $
KONSENS
52,45 $
MEDIAN
53,00 $
KURSZIEL HOCH
85,00 $
0
STRONG BUY
9
BUY
16
HOLD
4
SELL
0
STRONG SELL
29
GESAMT · Hold
| DATUM | ANALYSTENHAUS | RATING | AKTION |
|---|---|---|---|
| 06.01.2026 | Barclays | Equal Weight → Underweight | downgrade |
| 12.11.2024 | Jefferies | Buy → Hold | downgrade |
| 31.10.2024 | Guggenheim | Buy → Neutral | downgrade |
| 08.07.2024 | UBS | Buy → Neutral | downgrade |
| 02.07.2024 | Jefferies | Buy | maintain |
| 04.03.2024 | Guggenheim | Neutral → Buy | upgrade |
| 03.01.2024 | Jefferies | Hold → Buy | upgrade |
| 11.02.2022 | DZ Bank | Buy → Hold | downgrade |
KENNZAHLEN
KGV
13,99
KBV
4,57
EV/EBITDA
8,38
EIGENKAPITALRENDITE
7,4 %
NETTOMARGE
22,8 %
VERSCHULDUNG (D/E)
1,07
DIVIDENDENRENDITE
3,3 %
STAND
31.03.2026
FREE FLOAT & LIQUIDITÄT
STREUBESITZ
97,2 %
AKTIEN IM STREUBESITZ
1.946.162.400
Ø TAGESVOLUMEN (30T)
4.152.884
INVESTIERTE FONDS
| FONDS / INSTITUTION | ANTEILE | VERÄNDERUNG | STAND |
|---|---|---|---|
| Douglas Lane & Associates, LLC | 946.636 | -62.765 | 30.06.2026 |
| Thomasville National Bank | 871.467 | +871.467 | 30.06.2026 |
| ABC ARBITRAGE SA | 538.873 | -2.880 | 30.06.2026 |
| Capricorn Fund Managers Ltd | 426.416 | +426.416 | 30.06.2026 |
| Foster Victor Wealth Advisors, LLC | 414.286 | +19.691 | 30.06.2026 |
AKTIENSPLITS
| DATUM | VERHÄLTNIS |
|---|---|
| 22.07.2022 | 4:5 |
| 12.11.1991 | 2:1 |
| 27.01.1986 | 2:1 |
| 22.02.1983 | 2:1 |
| 13.02.1980 | 2:1 |
DIVIDENDEN
| EX-DATUM | ZAHLDATUM | BETRAG | RENDITE |
|---|---|---|---|
| 15.05.2026 | 09.07.2026 | 0,45 $ | 3,6 % |
| 20.02.2026 | 09.04.2026 | 0,48 $ | 3 % |
| 14.11.2025 | 08.01.2026 | 0,43 $ | 3,6 % |
| 15.08.2025 | 09.10.2025 | 0,43 $ | 4,2 % |
| 16.05.2025 | 10.07.2025 | 0,43 $ | 4,3 % |
Keine Anlageberatung. Vergangene Wertentwicklung ist kein Indikator für zukünftige Ergebnisse.